Advertisement
Gelteq Limited Ordinary Shares

Gelteq Limited Ordinary Shares (GELS) Stock Overview

Explore Gelteq Limited Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

GELSNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.62
$0.02(3.30%)
U.S. Market opens in 54h 49m
Advertisement

Gelteq Limited Ordinary Shares (GELS)

Meyka AI Score

Z

Key Financials

Market Cap6M
P/E Ratio0.00
EPS (TTM)$-0.50
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$1.37
3 Months$0.36
1 Year Target$0.00

GELS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gelteq Limited Ordinary Shares (GELS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.13%
5-Day Change
-36.99%
1-Month Change
53.79%
3-Month Change
-6.48%
6-Month Change
-24.94%
Year-to-Date (YTD) Change
-18.88%
1-Year Change
-65.48%
3-Year Change
-77.93%
5-Year Change
-77.93%
All-Time (Max) Change
-77.93%

Contact Information

61 3 9087 3990
641 Glen Huntly Road, Caulfield, VIC, 3162

Company Facts

70 Employees
IPO DateOct 29, 2024
CountryAU
Actively Trading

Frequently Asked Questions